Photo from Zev Wainberg from X
Jun 29, 2024, 10:55
Zev Wainberg discussing the 3-year OS data from the TOPAZ-1 trial
Lorenza Rimassa, Associate Professor of Medical Oncology at HUNIMED, shared on X:
“Zev Wainberg discussing the 3-year OS data from the TOPAZ-1 trial in biliary tract cancer and the OPTIMIZE-1 in pancreatic cancer. Which are the open questions and future perspectives?”
Source: Lorenza Rimassa/X
Aug 22, 2024, 17:45